Drug firm Wockhardt plans to launch 12-15 products in the US market this fiscal and also increase its reach in the European market. The company received 7 abbreviated new drug applications (ANDA) approvals this year. Currently, the company markets over 60 products in the US.
The company's sales during 2010-11 exceeded $225 million for the first time in the US. Apart from more product launches in the US, Wockhardt also plans to spread its reach to the entire European region. In Europe, in addition to the geographies where the company has operations, Wockhardt
The firm has plans to launch nine new products in the UK in this fiscal. will be reaching out to the entire Europe with products portfolio and manufacturing capacity through B2B model, n the domestic market, the company plans to enter new therapies and is developing task forces to gain market traction and expand the product portfolio.crackcrack
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1859.65 |
Dr. Reddys Lab | 1391.00 |
Cipla | 1507.95 |
Lupin | 2218.50 |
Zydus Lifesciences | 975.05 |
View more.. |